Skip to main content
Clinical Trials/NCT04033835
NCT04033835UnknownNot Applicable

Mentalization Based Treatment - Introductory Group for Male Prisoners With Borderline and/or Antisocial Personality Disorder in Her Majesty's Prison Barlinnie

NHS Greater Glasgow and Clyde1 site in 1 country30 target enrollmentStarted: August 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
30
Locations
1
Primary Endpoint
Completion of three MBT-I group cycles

Study Overview

Brief Summary

Established evidence base with MBT for treatment of Borderline Personality Disorder (BPD) and/or Antisocial Personality Disorder (ASPD). Demographic information of United Kingdom prison population highlights large proportion of offenders with PD. There is no agreed universal approach to treatment of PD within Scottish prisons with large variance across the prison estate. MBT pilots in HMP Edinburgh and HMP Cornton Vale have demonstrated positive findings in female offenders which could be replicated in male populations.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Primary diagnosis of BPD and/or ASPD
  • •Co-morbidity with other personality disorder is accepted
  • •Sentenced prisoners with estimated date of liberation > six months

Exclusion Criteria

  • •Co-morbid severe and enduring mental illness (schizophrenia, delusional disorder, bipolar affective disorder, major depressive disorder)
  • •Co-morbid organic brain disorder (acquired brain injury, alcohol related brain damage)
  • •Remand prisoners
  • •Uncontrolled substance dependence
  • •Index offence of sexual offending
  • •Repeatedly chaotic, antisocial or violent behaviour in prison
  • •Care in segregation and reintegration unit in past 3 months
  • •Current individual specialist psychological therapy in prison
  • •English as not first language

Arms & Interventions

MBT-I

Experimental

12 sessions of MBT

Intervention: Mentalization Based Treatment-Introductory (Other)

Waiting list control

Active Comparator

Treatment as usual

Intervention: Treatment as usual (Other)

Outcomes

Primary Outcomes

Completion of three MBT-I group cycles

Time Frame: 18 months

Participants to have attended ≥75% (9 or more out of 12) of scheduled sessions to consider this successful completion of the programme. ≥50% participants who commenced session one to have completed the intervention as described above to consider the group successful.

Secondary Outcomes

  • Quantitative data measuring change in difficulties with interpersonal relationships pre- and post-intervention(21 months)
  • Quantitative data measuring change in anxiety symptoms pre- and post-intervention(21 months)
  • Quantitative data measuring change in social functioning and satisfaction pre- and post-intervention(21 months)
  • Qualitative data from follow up interviews of participants examining understanding of and overall satisfaction of intervention(21 months)
  • Quantitative data measuring change in difficulties with impulsivity pre- and post-control(21 months)
  • Quantitative data measuring change in depressive symptoms pre- and post-intervention(21 months)
  • Quantitative data measuring change in anxiety symptoms pre- and post-control(21 months)
  • Quantitative data measuring change in difficulties with reflective functioning pre- and post-intervention(21 months)
  • Quantitative data measuring change in difficulties with interpersonal relationships pre- and post-control(21 months)
  • Quantitative data measuring change in difficulties with impulsivity pre- and post-intervention(21 months)
  • Quantitative data measuring change in difficulties with reflective functioning pre- and post-control(21 months)
  • Quantitative data measuring change in depressive symptoms pre- and post-control(21 months)
  • Quantitative data measuring change in overall symptoms and functioning pre- and post-intervention(21 months)
  • Quantitative data measuring change in overall symptoms and functioning pre- and post-control(21 months)
  • Quantitative data from behavioural proxy measures examining change in the number of challenging behaviours pre- and post-intervention(21 months)
  • Quantitative data from behavioural proxy measures examining change in the number of challenging behaviours pre- and post-control(21 months)
  • Quantitative data measuring change in social functioning and satisfaction pre- and post-control(21 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials